ONITT: A phase I study of nanoliposomal irinotecan with talazoparib or temozolomide in children and young adults with recurrent or refractory solid tumors. Promoting Resilience in Stress Management ...
A phase 1/2 study of JK06, a 5T4 antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancer. RYZ101 (225Ac-DOTATATE) in patients with estrogen receptor-positive, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results